Researchers at the Toronto Western Hospital (TWH) Liver Clinic have found that a simple drug regimen delivered over 12 weeks achieved sustained eradication of several genotypes of the hepatitis C virus (HCV) in 99 per cent of the trial’s patients.
The study, released today in the New England Journal of Medicine, showed that receiving a once daily drug combination of sofosbuvir-velpatasvir for a 12 week period was effective in both treatment-naïve and previously treated patients with HCV genotype 1, 2, 4, 5, or 6, including those with compensated cirrhosis (where scarring of the liver has occurred but patients have yet to experience symptoms as a result of it).
“This drug regimen changes the standard of care in treating patients with HCV – we can now cure almost everyone with a very simple treatment,” said Dr. Jordan Feld, Hepatologist, Francis Family Liver Clinic, TWH and the first author of the study. “It’s incredibly gratifying to be part of research where we not only cure a disease but can also think about eliminating HCV in Canada.”
Current approved treatments for chronic HCV are not equally effective in combating the virus’ different genotypes. Testing to determine the genotype and subtype of the virus is required before treatment could be initiated. But the combination of sofosbuvir-velpatasvir has been shown to be applicable to all strains of HCV, effectively eliminating the need to test for the viral genotype – an obstacle that often delayed treatment.
The regimen was tested in an international, randomized, double-blind placebo-controlled phase three trial conducted at 81 sites in eight different countries. After 12 weeks, 99 per cent of the 624 patients who had been treated with a daily tablet of sofosbuvir-velpatasvir experienced a sustained virologic response – the medical term for eradication or cure of HCV – meaning that patients remained free of the virus three months after completing treatment. None of the 116 patients receiving a placebo experienced the same result.
“This is truly a one size fits all treatment that is very easy to administer and extremely well tolerated,” said Dr. Feld. “Our challenge now is getting treatment to those who need it. Over half of people living with hepatitis C remain undiagnosed. Fortunately this regimen, along with other advances in therapy, will allow us to move treatment out of specialty clinics so that we can deliver care and ideally cure all infected Canadians.”
Chronic HCV is known as a “silent” killer because symptoms often don’t appear until the liver is severely damaged. Left undiagnosed, HCV can lead to cirrhosis which can progress to liver failure or liver cancer. HCV is primarily spread by blood-to-blood contact and is associated with intravenous drug use, contact with poorly sterilized medical equipment and blood transfusions before 1992.
Approximately 170 million people are infected with chronic HCV worldwide with an estimated 252,000 in Canada. HCV causes the greatest burden of disease, measured in years of life lost, than any infectious disease in Canada.?
Read more: SIMPLE DRUG REGIMEN CURES HEPATITIS C VIRUS IN PATIENTS AFTER 12 WEEKS
The Latest on: Hepatitis C
[google_news title=”” keyword=”Hepatitis C” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Hepatitis C
- Vitamin D levels associated with enhanced immune response against hepatitis B virus: Studyon May 12, 2024 at 8:15 pm
A recent study by Catharina Gerhards and colleagues looked in depth into the intricate relationship between vitamin D levels and immune response in patients with chronic hepatitis B (CHB) ...
- Missouri to host hepatitis C testing event at the Capitolon May 12, 2024 at 7:02 pm
The Missouri Department of Health and Senior Services will host a hepatitis C testing event at the state Capitol on May 20. Hepatitis C can result in cirrhosis and liver cancer, as well as ...
- Hepatitis C testing offered in 2 free clinics at Central Libraryon May 11, 2024 at 11:04 am
Connect to Cure is offering free Hepatitis C testing at two locations this May at ce3ntral Library in downtown Indianapolis ...
- Let’s make hepatitis C history in Canadaon May 10, 2024 at 3:00 am
Registered nurse Tina Woodruff from Niagara Health's hepatitis C care clinic tests a woman for the virus during a 2019 event to raise awareness and encourage more people to get tested. Canada has made ...
- Infected Blood Inquiry: Mother contracts hepatitis C from a 1971 blood transfusion - and doesn't find out for decadeson May 9, 2024 at 7:25 pm
Daphne Whitehorn contracted Hepatitis C from a blood transfusion she received during a kidney transplant in 1971. Her daughter Janice tested positive for the virus in 2019, probably infected when she ...
- Opinion: Let’s make hepatitis-C history in Canadaon May 9, 2024 at 4:03 pm
Thankfully for some survey participants, there were no cash prizes for correct answers. Because we got a lot of untrue statements. No, you don’t get hepatitis-C from eating or drinking contaminated ...
- Infected blood scandal: Hundreds ‘unaware they have hepatitis C’on May 9, 2024 at 5:44 am
Evidence suggests patients at risk after transfusions were not traced and warned by the NHS because it was too costly ...
- Nearly 2,000 people unaware they have hepatitis C from infected bloodon May 9, 2024 at 2:29 am
Around 1,750 people are living with an undiagnosed hepatitis C infection after being given contaminated blood, a BBC analysis has found.
- Infected blood: Hundreds of victims living with undetected hepatitis Con May 8, 2024 at 9:00 pm
About 1,750 people in the UK are living with an undiagnosed hepatitis C infection after being given a transfusion with contaminated blood, according to BBC analysis. The UK government and NHS failed ...
- DHEC Encourages Hepatitis C Testing During Hepatitis Awareness Monthon May 8, 2024 at 8:06 am
May is National Hepatitis Awareness Month, and the South Carolina Department of Health and Environmental Control is encouraging South Carolinians to know their status and get tested.
via Bing News